Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
If you have spent the last three years running a 503B outsourcing facility, you likely enjoyed a period of unprecedented growth fueled by a single class of molecules: glucagon-like peptide-1 (GLP-1) receptor agonists
The STEP-1 trial showed an average of 15% body weight loss over 68 weeks
Available in injectable and oral forms, this treatment utilizes the natural GLP-1 hormone to help reduce appetite and achieve sustainable weight loss
Adherence and injection technique also affect outcomes
Technically yes, but it is not recommended because it makes dosing calculations extremely complicated and increases the risk of errors
US$ 22.12
US$ 28.70
US$ 28.86
US$ 28.54
